Controversy in public hospital reforms in China

The Lancet Global Health

Volumn 4, Issue 4, 2016, Pages e240-

  Guan, Xiao ^a   Qi, Lin ^a   Liu, Longfei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; DRUG MARKETING; GOVERNMENT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL RUNNING COST; HUMAN; INCOME; LETTER; PRIORITY JOURNAL; PUBLIC HOSPITAL; DRUG COST; ECONOMICS; FEE; ORGANIZATION AND MANAGEMENT;

CHINA; DRUG COSTS; FEES AND CHARGES; HEALTH CARE REFORM; HEALTH CARE SECTOR; HOSPITALS, PUBLIC;

EID: 84962529937     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)00041-3     Document Type: Letter

References (2)

1. Press conference on Jan 15, 2016 (in Chinese) National Health and Family Planning Commission of People's Republic of China, (accessed Jan 17, 2016). http://www.nhfpc.gov.cn/xcs/s3574/201601/b3ba99c5611143dba51b2dd6e5a81831.shtml.
2. Diagrams about public hospitals' revenue: about forty percent comes from drug sales. The subsidy from the government only takes up a very small part (in Chinese) Min Nan Wang, (accessed Jan 17, 2016). http://www.mnw.cn/news/china/864219.html.